Effectiveness of an Intervention of Pharmacotherapeutic Plans to Reduce Medication-related Problems in Geriatric Residences

Last updated: July 5, 2023
Sponsor: Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

systematic and structured review of patient pharmacotherapeutic treatment plans

Clinical Study ID

NCT05944328
22/191-P
  • Ages 65-110
  • All Genders

Study Summary

Background: Patients living in Geriatric Residences (RG) have increased aging, comorbidity, spending on health resources and mortality. High drug use is associated with an increased risk of falls, disability, and death. It is estimated that 20-50% of inappropriate medications are consumed in the elderly.

Hypothesis: A pharmaceutical intervention based on a clinical review of the pharmacotherapeutic plan of patients in RG will be useful in optimizing the prescription in terms of safety, reducing by 10% or more the inappropriate prescriptions.

Objectives: Evaluate the effectiveness of a structured pharmaceutical intervention based on the clinical review of the pharmacotherapeutic plan to improve its adequacy.

Decrease inadequate prescriptions in patients admitted to RG by 10%

Methodology: Pre-post, quasi-experimental intervention study with control group with prospective follow-up of a cohort of patients in RG. The intervention consists of the clinical review of the pharmacotherapeutic plan carried out by the pharmacist and subsequently agreed in the Pharmacotherapeutic Advisory Committee.

Determinations: The study variables will be evaluated at baseline and 3 months post-intervention. The primary variable is number of inappropriate prescriptions.

Statistical analysis: Percentage change will be measured before and after the intervention. Descriptive statistics will be performed for quantitative variables such as qualitative and comparison of means and proportions.

Expected results: Achieve a 10% decrease in inappropriate prescriptions

Applicability and Relevance: This study will expand the collaboration between the Pharmacy and Primary Care physicians, promoting the continuum of care, strengthening the safety culture, and improving prescribing habits.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 65 years or older
  • Pharmacological treatment with at least one drug and for a period of more than threemonths

Exclusion

Exclusion Criteria:

  • Individuals who at the time of the pharmaceutical review were in hospital
  • Patients nearing the end of life
  • Patients whose participation was considered by the doctor responsible to bepotentially detrimental
  • Patients not covered by the public healthcare or pharmacy system were excluded.

Study Design

Total Participants: 862
Treatment Group(s): 1
Primary Treatment: systematic and structured review of patient pharmacotherapeutic treatment plans
Phase:
Study Start date:
February 22, 2023
Estimated Completion Date:
June 01, 2024

Connect with a study center

  • Cecilia Campabadal Prats

    Tarragona, 43003
    Spain

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.